Accessibility Menu

Virbac(FRA) V16

Market Cap€2.68BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€320.00
-0.78%
-2.50Today

Virbac Financials at a Glance

Market Cap

€2.68BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

€18.01

P/E Ratio

17.77

Dividend

€1.45

Beta (Volatility)

0.04 (Low)

Price

€320.00

Volume

0

Open

€317.00

Previous Close

€320.00

Daily Range

€317.00 - €321.00

52-Week Range

€303.50 - €381.00

Estimated Earnings Date

N/A

V16 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Virbac

Virbac SA engages in the manufacture and sale of veterinary medicines. The firm operates through the following segments: Companion Animals and Food Producing Animals. It develops vaccines, antibiotics, anesthetics, dermatological products, and drugs for pest control, inflammation, dental care, and ophthalmological conditions of pets and livestock. It also offers food and electronic identification chips. The company was founded by Pierre-Richard Dick and Max Rombi in 1968 and is headquartered in Carros, France.

Industry

Pharmaceuticals

Sector

Health Care

Employees

6,442

CEO

Paul Martingell, MBA

Website

www.virbac.fr

V16 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

13.92%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

5.63%

Dividend Yield

0.45%

Payout Ratio

N/A

Stock Overview

Market Cap

€2.68BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

8.38M

Volume

0

Avg. Volume

0.667

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Virbac Performance Analysis

Virbac annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 1,216,187,00014.3%
20232023-12-31EUR 1,246,901,0002.5%
20242024-12-31EUR 1,397,380,00012.1%
20252025-12-31EUR 1,464,677,0004.8%
Virbac annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 14.427.7%
20232023-12-31EUR 14.38-0.3%
20242024-12-31EUR 17.3420.6%
20252025-12-31EUR 18.003.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

€2.68BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About V16

What is the current price of Virbac?

Virbac is trading at €320.00 per share.

What is the 52-week range for Virbac?

Over the past 52 weeks, Virbac has traded between €303.50 and €381.00.

How much debt does Virbac have?

As of the most recent reporting period, Virbac reported total debt of €290.55M.

How much cash does Virbac have on hand?

Virbac reported €122.50M in cash and cash equivalents in its most recent financial results.

What is Virbac’s dividend yield?

Virbac currently has a dividend yield of 0.45%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services